Literature DB >> 19133718

Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles.

Geneviève Gaucher1, Kinji Asahina, Jiaohong Wang, Jean-Christophe Leroux.   

Abstract

The effect of the coating polymer poly(N-vinyl-pyrrolidone) (PVP) on the protein adsorption, phagocytosis, and pharmacokinetics of poly(D,L-lactide)-based nanoparticles was evaluated in vitro and in vivo. Control poly(ethylene glycol) (PEG)-coated nanoparticles were included for comparison. While no difference between PEG- and PVP-decorated nanoparticles in terms of amount of adsorbed protein was evident upon incubation in single protein solutions (BSA, IgG), incubation in serum revealed a protein adsorption pattern both quantitatively and qualitatively distinct. Larger amounts of complement components and immunoglobulins were found to adhere to PVP-coated particles, whereas PEG particles showed preferential adsorption of apolipoproteins. Furthermore, preopsonization in fresh rather than heat-inactivated serum enhanced uptake of both types of particles by murine RAW 264.7 macrophages. However, when isolated rat Kupffer cells were employed, activation of the complement system significantly enhanced the uptake of PVP-coated nanoparticles compared to PEG particles. Ultimately, PVP-coated nanoparticles exhibited considerably shorter circulation times compared to their PEG counterparts when administered intravenously to rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133718     DOI: 10.1021/bm801178f

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  21 in total

Review 1.  The new toxicology of sophisticated materials: nanotoxicology and beyond.

Authors:  Andrew D Maynard; David B Warheit; Martin A Philbert
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

Review 2.  Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications.

Authors:  Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-15       Impact factor: 4.939

3.  Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery.

Authors:  Jun Chen; Sithira Ratnayaka; Aaron Alford; Veronika Kozlovskaya; Fei Liu; Bing Xue; Kenneth Hoyt; Eugenia Kharlampieva
Journal:  ACS Nano       Date:  2017-03-10       Impact factor: 15.881

4.  Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Authors:  Bin Shi; Ed Keough; Andrea Matter; Karen Leander; Stephanie Young; Ed Carlini; Alan B Sachs; Weikang Tao; Marc Abrams; Bonnie Howell; Laura Sepp-Lorenzino
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

5.  Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.

Authors:  Shuangshuang Song; Huan Qi; Jingwen Xu; Pan Guo; Fen Chen; Fei Li; Xinggang Yang; Naicheng Sheng; Yingliang Wu; Weisan Pan
Journal:  Pharm Res       Date:  2014-05-20       Impact factor: 4.200

6.  Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat.

Authors:  Yvan Wenger; Randal J Schneider; G Ramachandra Reddy; Raoul Kopelman; Olivier Jolliet; Martin A Philbert
Journal:  Toxicol Appl Pharmacol       Date:  2010-12-04       Impact factor: 4.219

Review 7.  Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  J Control Release       Date:  2013-06-03       Impact factor: 9.776

8.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.

Authors:  Kai Xiao; Yuanpei Li; Juntao Luo; Joyce S Lee; Wenwu Xiao; Abby M Gonik; Rinki G Agarwal; Kit S Lam
Journal:  Biomaterials       Date:  2011-02-04       Impact factor: 12.479

9.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors:  Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

10.  Nanoparticle Uptake: The Phagocyte Problem.

Authors:  Heather Herd Gustafson; Dolly Holt-Casper; David W Grainger; Hamidreza Ghandehari
Journal:  Nano Today       Date:  2015-09-05       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.